Syqe Medical Ltd

Syqe Medical Ltd specializes in the development and production of the SyqeAir inhaler system. This is a metered-dose inhaler designed specifically for the controlled administration of medical cannabis to help manage pain. The device is engineered to deliver precise, measured doses of cannabis-based formulations for therapeutic use.

Syqe Medical Ltd is based in Israel. The company’s headquarters and operations are located within the country, where it develops and manufactures its medical devices.

Syqe Medical Ltd’s devices, including the SyqeAir inhaler system, are registered in the eudamed database. This is the European Union’s central registry for medical devices, ensuring transparency and traceability of devices marketed within the EU.

The SyqeAir inhaler system is classified as a Class IIa medical device. This classification is determined based on its intended use, risk profile, and the potential impact on patient safety. Class IIa devices are considered to have a moderate risk and require compliance with specific regulatory requirements to ensure their safety and performance.